A fertility startup betting that IVF can cost a third of what Americans currently pay is opening its first clinic in West Palm Beach this fall.
The American Baby Company has raised a $4 million seed round co-led by Tower Research Ventures and Wormhole Capital, and will offer a full IVF cycle, medications included, for $8,995, against a national average of roughly $23,500. Egg freezing will run $4,995.
The math behind that gap is the whole business case. About one in eight American couples struggles with infertility, yet only 14% of those who need fertility care actually receive IVF. Most patients require more than one cycle, which pushes the true cost toward $50,000 per child, roughly 70% of the median American household's post-tax annual income. The United States is the world's most expensive IVF market: a single cycle absorbs about half the average household's disposable income, compared with 20% in the United Kingdom and 12% in Japan. The result is a country performing fewer than a third of the IVF cycles per capita seen in Australia or Spain.
"This is personal for me. My fiancé and I went through IVF ourselves, including multiple failed cycles. That experience pushed me to build the kind of fertility company we wished had existed when we began treatment." — says CEO and co-founder Van Spina.
Spina spent his early career as a technology investor at Warburg Pincus before founding an institutionally backed data business in private credit.
The model rests on a diagnosis of why American fertility care costs what it does: the system is built around the most complex cases and priced accordingly. ABC identifies patients well suited to a streamlined pathway up front, generally women under 35 with regular cycles and strong ovarian reserve, and routes routine procedures to trained generalist clinicians working under specialist oversight, with specialists moving into medical-director roles focused on protocols and genuinely complex cases. Evidence-based protocols, AI-assisted intake, and modern lab workflows replace the manual coordination that drives overhead at a traditional clinic. Patients who aren't a fit don't pay, and the company says it will help them find appropriate care elsewhere.
The clinical credibility comes from co-founder and Chief Medical Officer Dr. Paul Magarelli, a board-certified reproductive endocrinologist who developed the Clinical Fertility Physician certification program that trains generalist clinicians to perform routine fertility procedures under specialist supervision, the precise mechanism ABC's cost structure depends on.
West Palm Beach being the launch market says something about where the city now sits. A venture-backed healthcare startup with national ambitions chose a South Florida address for its flagship, in a metro that has spent the past several years accumulating hundreds of financial firms, corporate relocations, and the medical infrastructure that follows wealth: Cleveland Clinic, Vanderbilt's planned graduate campus, NYU Langone's Julia Koch Family Ambulatory Care Center rising downtown. ABC will serve patients across South Florida from the West Palm Beach clinic, with a registration list for other markets. Spina's stated ten-year goal is to help make 250,000 babies a year.